Use of beta recombinase in eukaryotic cells, especially for transgenic work
US6780644B1 · kind B1 · utility
0Cited by
3References
41Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 22, 1998 |
| Grant date | Aug 24, 2004 |
| Priority date | — |
| Expiry date | Sep 22, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of prokaryotic beta recombinase in eukaryotic cells, especially for transgenic work in eukaryotic cells.It also relates to the use of prokaryotic beta recombinase for site-specific intramolecular recombination between two six sites in eukaryotic cells.The use of the gene coding for beta recombinase for promoting the deletion of DNA sequences located between directly oriented six sites in mammalian cells and for catalysing site-specific resolution of DNA sequences in an extrachromosomal target introduced into an eukaryotic cell are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.